EBMT 2023 | Efficacy of CD45RA- T-cell infusion to treat infections in immunocompromised patients and EBV-LPDs
Antonio Pérez-Martínez
• 23 Apr 2023
Antonio Perez-Martinez, MD, PhD, La Paz University Hospital, Madrid, Spain, discusses the use of CD45RA- cells containing cytotoxic T lymphocytes (CTLs) to treat severe refractory infections and EBV lymphoproliferative diseases (LPDs) immunocompromised patients. The poster, which was presented by Dr Perez-Martinez at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France, demonstrates a feasible adoptive cell therapy that could be a safe and effective approach for treating severe infections.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
